UPL Limited (UPL) — Board Meeting(3 announcements)

UPL Limited disclosed that CARE Ratings' Monitoring Agency Report for the quarter ended March 31, 2026 confirms full utilization of ₹3,377.74 crore raised via rights issue, with no deviations from stated objects. The report verifies compliance with SEBI regulations, including utilization of funds for debt repayment, working capital, and general corporate purposes within permitted limits. All statutory approvals were secured, and no material deviations or conflicts of interest were identified. The company completed all planned expenditures, including ₹3,003.9 crore for debt repayment and ₹341.9 crore for working capital, with ₹23.1 crore allocated to issue-related expenses. The final report, certified by Vora & Associates, confirms zero unutilized proceeds and full adherence to the offer document terms.

UPL announced the re-appointment of Ms. Naina Lal Kidwai as an Independent Director for a five-year term effective October 1, 2026, to September 30, 2031, pending shareholder approval. Her extensive experience in finance and sustainability strengthens the board's governance and strategic oversight capabilities.

UPL Limited's board approved audited financial results for FY2026 ending March 31, recommending a 300% dividend (Rs. 6 per share) subject to shareholder approval at the upcoming AGM. The results, audited by BSR & Co. LLP with an unmodified opinion, show consolidated revenue of Rs. 57,513 crores and net profit of Rs. 4,580 crores. The filing confirms regulatory compliance and includes global audit coverage across 200+ entities. A key proposed scheme of arrangement involving business amalgamations and demergers remains pending regulatory and shareholder approvals.